M. Rodriguez-arias et al., Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice, PHARM BIO B, 64(1), 1999, pp. 123-130
Dopamine seems to play a very important role in aggressive behavior observe
d in morphine withdrawal. The effect of SCH 23390 (0.5 mg/kg), raclopride (
0.3 mg/kg), and haloperidol (0.1 mg/kg) on morphine withdrawal-induced aggr
ession has been studied in this work. Mice were rendered dependent by a dai
ly injection of morphine (2.5 mg/kg) for 14 days. Three different experimen
ts were carried out with the objective to evaluate the antiaggressive effec
t of the dopamine antagonists on: first, spontaneous morphine withdrawal; s
econd, naloxone-induced withdrawal; and third, naloxone-induced withdrawal
after previous administration of the neuroleptics. Thirty minutes after inj
ection of the dopamine antagonists, experimental animals were confronted in
a neutral area with anosmic, group-housed conspecifics (standard opponents
), and aggression was evaluated by estimation of times allocated to 11 diff
erent behavioral categories. Morphine withdrawal produced an increase in ag
gressive behavior and a decrease in social and nonsocial behaviors. The thr
ee neuroleptics counteracted this aggression, but when SCH 23390 (selective
D-1 antagonist) and haloperidol (mixed D-1/D-2 antagonist) were administer
ed in naloxone-induced withdrawal, the effect was greater in comparison to
the spontaneous withdrawal. However, no changes were observed after raclopr
ide administration (selective D-2 antagonist). In conclusion, the alteratio
ns in the dopaminergic system produced by opiate withdrawal depend on the t
ype of withdrawal produced, and this produces a change in the antiaggressiv
e potency of the dopamine antagonists. (C) 1999 Elsevier Science Inc.